Safety of dermatologic medications in pregnancy and lactation: An Update - Part I: Pregnancy
The breadth of therapeutic options for the management of dermatologic skin conditions continues to expand rapidly as exemplified by biologics and small molecule drug development. While dermatologists and healthcare providers are aware of the underlying mechanisms and indications for these therapeutics, there is a recognized practice gap due to an incomplete understanding of the safety of these medications in women of childbearing age during the prepartum, antepartum and postpartum phases. Although a two-part continuing medical education review was published regarding the prescribing practices and safety profiles of these new therapeutics in women of childbearing age while pregnant or lactating in 20141,2, many new medications have been approved since then.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Authors: Patrick McMullan, Marita Yaghi, Thu M. Truong, Marti Rothe, Jenny Murase, Jane M. Grant-Kels Tags: Continuing Medical Education Source Type: research
More News: Academies | Child Development | Continuing Medical Education | Dermatology | Education | Grants | Pregnancy | Skin | Universities & Medical Training | Women